Group One Trading’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,073
| Closed | -$31K | – | 8941 |
|
|
2025
Q4 | $31K | Buy |
1,073
+112
| +12% | +$2.13K | ﹤0.01% | 5991 |
|
|
2025
Q3 | $7.46K | Sell |
961
-433
| -31% | -$3.25K | ﹤0.01% | 7342 |
|
|
2025
Q2 | $10.3K | Buy |
1,394
+590
| +73% | +$5.18K | ﹤0.01% | 6699 |
|
|
2025
Q1 | $6.92K | Sell |
804
-1,287
| -62% | -$19.9K | ﹤0.01% | 6488 |
|
|
2024
Q4 | $74.8K | Buy |
2,091
+788
| +60% | +$40.8K | ﹤0.01% | 4757 |
|
|
2024
Q3 | $61.6K | Buy |
1,303
+364
| +39% | +$16.1K | ﹤0.01% | 4510 |
|
|
2024
Q2 | $47.2K | Buy |
+939
| New | +$67.9K | ﹤0.01% | 4560 |
|
|
2024
Q1 | – | Sell |
-1,243
| Closed | -$124K | – | 8271 |
|
|
2023
Q4 | $72.1K | Sell |
1,243
-440
| -26% | -$17.7K | ﹤0.01% | 4754 |
|
|
2023
Q3 | $53.4K | Sell |
1,683
-4,729
| -74% | -$225K | ﹤0.01% | 5036 |
|
|
2023
Q2 | $527K | Buy |
6,412
+6,328
| +7,533% | +$926K | 0.02% | 2959 |
|
|
2023
Q1 | $8.63K | Buy |
+84
| New | +$11.8K | ﹤0.01% | 6016 |
|
|
2022
Q4 | – | Sell |
-30
| Closed | -$5.07K | – | 8373 |
|
|
2022
Q3 | $5K | Sell |
30
-51
| -63% | -$8.29K | ﹤0.01% | 6835 |
|
|
2022
Q2 | $9K | Sell |
81
-644
| -89% | -$60.6K | ﹤0.01% | 6815 |
|
|
2022
Q1 | $72K | Buy |
725
+672
| +1,268% | +$78.5K | ﹤0.01% | 5810 |
|
|
2021
Q4 | $8K | Sell |
53
-101
| -66% | -$19.6K | ﹤0.01% | 7464 |
|
|
2021
Q3 | $36K | Buy |
+154
| New | +$45K | ﹤0.01% | 6790 |
|
|
2021
Q2 | – | Sell |
-355
| Closed | -$134K | – | 8933 |
|
|
2021
Q1 | $144K | Buy |
355
+195
| +122% | +$94.6K | ﹤0.01% | 5319 |
|
|
2020
Q4 | $107K | Buy |
+160
| New | +$89K | ﹤0.01% | 4515 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6821 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6445 |
|